| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |